Blastomycosis

Blastomycosis is a systemic fungal infection caused by Blastomyces dermatitidis, a dimorphic fungus that exists in a mold form in the environment and converts to a yeast form when it infects warm-blooded hosts. This disease primarily affects dogs but can also infect cats, humans, and other mammals. Blastomycosis is geographically restricted to endemic areas, primarily the Mississippi River valley, Ohio River valley, Great Lakes region, and southeastern United States, though cases occur in other areas including parts of Canada. Cats living in or traveling through these endemic zones are at risk of infection through inhalation of environmental spores.

The infection develops when cats inhale Blastomyces spores from contaminated soil, particularly in areas near waterways, with acidic, moist, sandy soil rich in organic matter. The fungal spores convert to yeast form in the lungs and can either be contained by the immune system or spread throughout the body via the bloodstream and lymphatic system. While the lungs are the primary site of infection, blastomycosis commonly disseminates to affect the skin, eyes, bones, lymph nodes, and other organs. The disease tends to be less common in cats than dogs, but feline cases are regularly diagnosed in endemic regions.

The impact of blastomycosis on affected cats ranges from relatively mild localized infection to severe, life-threatening systemic disease. Respiratory involvement causes coughing, labored breathing, and exercise intolerance. Skin lesions develop as draining nodules or non-healing wounds. Eye involvement can lead to blindness. Bone infection causes lameness and pain. The disease progresses without treatment and can be fatal. Even with treatment, some cats experience significant morbidity from organ damage that occurred before diagnosis.

Blastomycosis in cats is treatable with antifungal medications, though treatment must be prolonged, typically lasting months. Itraconazole is the most commonly used antifungal for feline blastomycosis, with good efficacy and acceptable tolerability. Early diagnosis and treatment improve prognosis significantly, as cats with less extensive disease at the time of diagnosis respond better than those with widespread involvement. With appropriate treatment, many cats recover completely, though relapses can occur, particularly if treatment is discontinued prematurely.

The cause of blastomycosis is infection with Blastomyces dermatitidis, a dimorphic fungus meaning it exists in two forms depending on temperature. In the environment at cooler temperatures, Blastomyces grows as a mold producing infectious spores called conidia. When these spores are inhaled by a warm-blooded host, they convert to a larger yeast form that is responsible for causing disease. This yeast form has a characteristic thick double-contoured cell wall and reproduces by budding. The organism has recently been reclassified and what was previously considered a single species is now known to include multiple species in the Blastomyces genus, including Blastomyces gilchristii.

Blastomycosis is not a hereditary or genetic condition, and there is no known breed predisposition in cats. The disease results entirely from environmental exposure to the fungus rather than any inherited susceptibility. While individual immune responses may vary and affect disease severity, there are no identified genetic factors that specifically predispose cats to blastomycosis infection. All cats in endemic areas face potential exposure risk regardless of breed or genetic background.

Environmental factors are the primary determinants of blastomycosis risk. The fungus thrives in specific ecological niches characterized by moist, acidic, sandy soil rich in organic material, particularly decaying wood and vegetation. Proximity to waterways including rivers, lakes, streams, and beaver dams significantly increases exposure risk. The fungus concentrates in areas where soil has been disturbed, such as construction sites, areas of excavation, or locations where organic debris accumulates. Seasonal patterns exist, with increased cases often following periods of rainfall or in certain seasons when soil conditions favor fungal growth and sporulation.

Risk factors for developing blastomycosis relate primarily to geographic location and outdoor exposure. Living in or traveling through endemic regions is the fundamental risk factor, as the disease does not occur outside these areas. Outdoor cats with access to natural environments have higher exposure than indoor-only cats. Activities that disturb contaminated soil, such as digging, increase spore release and exposure. Young male cats appear overrepresented in some case series, possibly reflecting greater roaming behavior and environmental exposure. Immunocompromised cats may be at higher risk for developing clinical disease following exposure.

The mechanism of disease development begins with inhalation of airborne conidia into the lower respiratory tract. These small spores are well-suited to reaching the alveoli where they encounter warm temperatures that trigger conversion to the yeast form. The yeast multiplies and establishes primary pulmonary infection. In immunocompetent hosts, the infection may be contained at this stage or even eliminated. However, in many cases, the yeast spreads via lymphatics and bloodstream to other organs. The thick cell wall of Blastomyces yeast helps it evade host immune responses. A robust cell-mediated immune response is required to control infection, making immunocompromised individuals particularly susceptible to progressive disease.

Early warning signs of blastomycosis in cats are often subtle and nonspecific, making early detection challenging. Initial symptoms may include mild lethargy, slight reduction in appetite, or subtle changes in activity level that owners attribute to other causes. A dry, non-productive cough may develop early but can be intermittent and not alarming. Low-grade fever that is not detectable by owners may be present. Because the incubation period following exposure can range from weeks to months, the connection between environmental exposure and developing symptoms is often not recognized. The insidious onset means many cats have established infection before obvious symptoms develop.

As blastomycosis progresses, respiratory symptoms often become the most prominent feature. Coughing becomes more frequent and may progress from dry to productive. Labored breathing and increased respiratory effort develop as pulmonary involvement worsens. Exercise intolerance manifests as reluctance to play or rapid fatigue. Harsh lung sounds may be audible. Some cats develop nasal discharge if the upper respiratory tract is involved. Respiratory signs can be severe enough to cause open-mouth breathing in advanced cases. Weight loss accompanies systemic illness.

Skin manifestations are common in feline blastomycosis and may be the most visible sign to owners. Nodules develop under the skin that may ulcerate and drain thick purulent material. Lesions commonly occur on the face, nose, and feet but can develop anywhere on the body. These wounds fail to heal despite treatment for presumed bacterial infection. Hair loss occurs around affected areas. Multiple lesions may be present. Lymph nodes, particularly those draining affected skin areas, become enlarged and may themselves develop draining tracts.

Ocular involvement is a significant feature of blastomycosis in cats and can lead to permanent vision impairment. Affected eyes may appear cloudy or have visible abnormalities including redness, swelling, or pupil changes. Signs of eye pain include squinting, excessive tearing, and light sensitivity. Blindness may develop if infection damages intraocular structures. Both eyes may be affected though unilateral involvement is also common. Owners may notice their cat bumping into objects or reluctance to navigate in dim light.

Symptom progression reflects the systemic nature of blastomycosis if left untreated. Initial pulmonary infection spreads to involve additional organs. Skin lesions increase in number and size. Bone involvement causes progressive lameness and pain. Neurological signs may develop with central nervous system infection. Weight loss becomes marked as chronic infection causes wasting. Affected cats become progressively weaker and more debilitated. Without treatment, the disease is frequently fatal due to respiratory failure or multi-organ dysfunction.

Emergency symptoms requiring immediate veterinary attention include severe respiratory distress with open-mouth breathing, cyanosis, or collapse. Sudden loss of vision or severe eye pain warrants urgent evaluation. Neurological signs including seizures, severe incoordination, or paralysis are emergencies. High fever with profound lethargy and complete anorexia indicates severe systemic illness. Any rapid deterioration in a cat previously diagnosed with blastomycosis needs immediate assessment. Cats in endemic areas with compatible symptoms should be evaluated promptly even before emergent signs develop.

Initial veterinary examination for suspected blastomycosis involves comprehensive evaluation of history and clinical findings. The veterinarian will specifically inquire about geographic history, including residence in or travel through endemic areas, and outdoor access. Physical examination evaluates respiratory status including auscultation of lungs, examination of skin for characteristic lesions, palpation of lymph nodes for enlargement, ophthalmologic examination for ocular involvement, and orthopedic evaluation if lameness is present. The combination of respiratory signs, skin lesions, and ocular abnormalities in a cat from an endemic area raises strong suspicion for blastomycosis.

Diagnostic testing employs multiple modalities to confirm blastomycosis and assess disease extent. Thoracic radiographs typically show characteristic pulmonary patterns, most commonly a diffuse miliary nodular pattern though other presentations occur. Cytology is the quickest route to diagnosis, with impression smears or needle aspirates from skin lesions, draining tracts, or enlarged lymph nodes often revealing the characteristic thick-walled, broad-based budding yeast organisms. Urine antigen testing for Blastomyces is available and provides a non-invasive diagnostic option with good sensitivity. Serology measuring antibodies is less reliable for diagnosis.

Additional diagnostics help assess the extent of infection and overall patient status. Complete blood count may show inflammatory changes with elevated white blood cells, anemia of chronic disease, and sometimes low platelet count. Serum chemistry evaluates organ function and may reveal abnormalities if kidneys, liver, or other organs are affected. Urine analysis may show protein or other abnormalities with urinary tract involvement. Bone lesions may be detected on radiographs of affected limbs if lameness is present. Ocular examination including fundoscopy evaluates eye involvement. Advanced imaging with CT or MRI may be warranted if central nervous system involvement is suspected.

Differential diagnosis for blastomycosis includes other systemic fungal infections and various non-fungal conditions. Histoplasmosis, another endemic fungal disease with overlapping geographic distribution, causes similar respiratory and systemic signs. Cryptococcosis is an important differential, particularly for cats with skin and eye lesions. Bacterial pneumonia may initially mimic pulmonary blastomycosis. Neoplasia, particularly lymphoma, can cause similar multiorgan involvement. Tuberculosis and other mycobacterial infections may present comparably. The geographic history combined with demonstration of characteristic organisms provides definitive diagnosis.

Initial treatment of severely ill cats with blastomycosis may require hospitalization for supportive care while antifungal therapy is initiated. Cats with respiratory distress may need oxygen supplementation. Intravenous fluid therapy addresses dehydration from reduced intake. Nutritional support maintains caloric intake in anorectic patients. Pain management addresses discomfort from skin lesions, bone involvement, or generalized illness. Any secondary bacterial infections are treated appropriately. Stabilization allows cats to tolerate the initiation of antifungal therapy that will address the underlying infection.

Antifungal medication is the definitive treatment for blastomycosis and must be continued for extended periods. Itraconazole is the most commonly used antifungal for feline blastomycosis, with good efficacy and generally acceptable tolerability. It is typically administered once or twice daily and must be given with food for optimal absorption. Fluconazole is an alternative with excellent tissue penetration, particularly useful for CNS or ocular involvement. Amphotericin B may be used for severe or refractory cases, though its nephrotoxicity requires careful monitoring. Treatment duration is typically a minimum of two to three months and often extends to six months or longer, continuing for at least one to two months beyond resolution of all clinical signs.

Management of specific organ involvement accompanies systemic antifungal therapy. Ocular blastomycosis may require topical anti-inflammatory and antifungal medications in addition to systemic treatment. Severe intraocular disease may necessitate enucleation if vision is lost and the eye is painful. Skin lesions are managed with wound care while systemic therapy takes effect. Bone lesions rarely require surgical intervention as they typically respond to medical treatment, though severely affected bones may need support or activity restriction. Respiratory disease may need supplemental oxygen initially while antifungal therapy reduces pulmonary organism burden.

Supportive care enhances outcomes and patient comfort throughout the treatment period. Maintaining adequate nutrition supports immune function and tissue healing. Appetite stimulants may help cats that are not eating well. Monitoring body weight tracks overall condition. Environmental modifications reduce stress and support recovery. Activity restriction may be necessary for cats with bone involvement. Regular gentle cleaning of draining skin lesions promotes healing. Keeping cats indoors prevents additional environmental exposure and allows monitoring.

Monitoring during treatment assesses response and watches for medication side effects. Clinical improvement should be evident within one to two weeks of starting appropriate therapy, with resolution of fever, improved appetite, and increased energy. Skin lesions gradually heal over weeks. Respiratory signs should improve progressively. Periodic recheck examinations assess progress. Thoracic radiographs may be repeated to evaluate pulmonary improvement. Liver enzymes should be monitored periodically as itraconazole can cause hepatotoxicity. Urine antigen testing may be useful for monitoring treatment response and determining when treatment can be discontinued.

Treatment decisions balance disease severity, prognosis, and practical considerations. Cats with mild to moderate disease have good prognosis with appropriate treatment. Those with severe pulmonary involvement, CNS infection, or multiple organ systems affected have more guarded prognosis. Treatment cost is significant given the extended duration of therapy and monitoring requirements. Owner commitment to prolonged daily medication administration is essential for success. Despite these challenges, treatment is worthwhile for most cats as complete recovery is achievable with appropriate therapy.

Recovery timeline for blastomycosis is extended given the nature of systemic fungal infection and the prolonged treatment required. Initial clinical improvement, including reduction in fever, improved appetite, and increased energy, typically occurs within the first one to two weeks of effective antifungal therapy. Skin lesions begin healing but may take weeks to months for complete resolution. Pulmonary abnormalities improve gradually over weeks to months, with radiographic improvement often lagging behind clinical improvement. Complete resolution of disease typically requires three to six months or longer of continuous treatment.

Post-treatment care involves confirming disease resolution and monitoring for relapse. Treatment should continue for at least one to two months after all clinical signs have resolved. Recheck examinations assess for any residual signs of disease. Repeat thoracic radiographs document resolution of pulmonary lesions. Urine antigen testing, if initially positive, should become negative with successful treatment, and persistent positivity suggests ongoing infection. After completing treatment, monitoring continues for several months as relapses can occur, particularly in the first three to six months following treatment discontinuation.

Prognosis for feline blastomycosis depends on multiple factors. Cats diagnosed early with less severe disease have better outcomes than those with extensive involvement at presentation. Pulmonary disease without dissemination has a better prognosis than widespread systemic infection. Ocular involvement may result in permanent vision impairment even with successful systemic treatment. CNS involvement carries a more guarded prognosis. Cats that respond well initially and complete the full course of treatment have good long-term outlook. Immunocompetent cats generally have better outcomes than immunocompromised individuals.

Long-term outlook for cats successfully treated for blastomycosis is generally good. Many cats achieve complete cure with no recurrence when treatment is appropriately prolonged. Relapses occur in a subset of cases, most commonly if treatment was discontinued prematurely, and can usually be successfully retreated. Cats that recover have normal life expectancy, though any permanent organ damage from the infection persists. Some cats, particularly those with severe ocular disease, may have lasting visual impairment. Close monitoring for the first year after treatment helps detect any relapses early when they are more easily managed.

Primary prevention of blastomycosis centers on reducing exposure to the causative fungus in endemic areas. The most effective prevention is keeping cats indoors, eliminating exposure to contaminated soil environments. For cats that must have outdoor access in endemic regions, avoiding areas near waterways, beaver dams, and locations with moist, rich soil reduces risk. Keeping cats away from areas where soil has been recently disturbed, such as construction sites or freshly tilled gardens, limits exposure to released spores. There is no vaccine available for blastomycosis prevention in cats or other animals.

Environmental awareness in endemic regions helps identify higher-risk situations. Understanding the geographic distribution of Blastomyces allows owners to assess their local risk. Areas with documented blastomycosis cases in humans, dogs, or cats indicate environmental presence of the fungus. Proximity to major waterways in the Mississippi and Ohio River valleys, Great Lakes region, and southeastern United States increases risk. Awareness of environmental conditions that favor fungal growth, including warm, moist conditions following rainfall, helps identify times of potentially higher spore release.

Dietary measures do not directly prevent blastomycosis since the infection results from inhaled environmental spores rather than dietary exposure. However, maintaining optimal nutrition supports immune function that may help the body contain infection if exposure occurs. A complete and balanced diet appropriate for the cat's life stage maintains overall health. Good body condition supports immune competence. While diet cannot prevent exposure, good nutritional status may influence whether exposure results in clinical disease.

Health maintenance practices support the cat's ability to resist or contain infection. Regular veterinary care maintains overall health. Addressing any conditions that might compromise immune function reduces susceptibility to opportunistic and endemic fungal infections. Avoiding or minimizing immunosuppressive medications when possible maintains immune competence. Testing for immunosuppressive viral infections in cats at risk allows appropriate management. Keeping cats healthy overall provides the best defense against developing clinical blastomycosis if exposure occurs.

Early intervention when respiratory or skin symptoms develop in cats from endemic areas enables prompt diagnosis and treatment. Any cat in an endemic region developing chronic cough, labored breathing, non-healing skin lesions, or eye abnormalities should be evaluated for blastomycosis. Owners should inform veterinarians of geographic history that might include endemic areas. Early diagnosis before extensive disease development significantly improves treatment outcomes. Awareness of blastomycosis as a possibility helps ensure appropriate diagnostic testing is performed rather than pursuing other diagnoses exclusively.

Daily management of a cat undergoing blastomycosis treatment requires consistent medication administration over an extended period. Antifungal medications must be given on schedule, typically once or twice daily with food for itraconazole. Establishing a routine helps ensure doses are not missed. Monitoring food and water intake helps assess well-being. Observing breathing pattern and effort tracks respiratory status. Examining skin lesions for healing progress provides visible evidence of treatment response. Recording weight periodically helps monitor overall condition.

Home environment modifications support recovery from blastomycosis. Keeping the cat indoors prevents additional environmental exposure and allows close monitoring. Providing warm, comfortable resting areas accommodates reduced energy during recovery. Easy access to food, water, and litter boxes minimizes effort required for essential activities. Reducing stress through stable routines and calm household management supports immune function. For cats with vision impairment from ocular involvement, keeping furniture and obstacles in consistent locations helps navigation.

Quality of life considerations guide management throughout the treatment period. Pain management addresses discomfort from skin lesions, bone involvement, or generalized illness. Appetite stimulants or highly palatable foods encourage eating in cats with reduced appetite. Gentle wound care keeps skin lesions clean without causing additional discomfort. Allowing rest while providing gentle interaction maintains social bonds. Adjusting activity level to the cat's current capability prevents overexertion. The goal is maintaining comfort and well-being while pursuing potentially curative treatment.

Monitoring during treatment tracks both treatment response and potential medication side effects. Clinical improvement should be evident within one to two weeks, with improved appetite, energy, and attitude. Skin lesions should show progressive healing. Breathing should become easier. Any worsening of symptoms warrants veterinary contact. Monitoring for signs of potential liver toxicity from antifungal medication, including reduced appetite, vomiting, or yellowing of gums, allows early intervention. Regular veterinary rechecks assess progress and catch any problems early.

Caregiver support helps owners maintain treatment commitment over the prolonged therapy duration. Understanding the expected timeline helps set realistic expectations. Knowing that improvement takes weeks to months maintains hope during early treatment. Organizing medication administration into daily routines improves compliance. Communicating regularly with the veterinary team provides support and allows addressing concerns. Connecting with others who have treated cats for blastomycosis may provide practical tips and emotional support. Acknowledging the commitment required and celebrating progress maintains caregiver morale.

Blastomycosis in cats does not demonstrate breed predisposition, as risk is determined by environmental exposure rather than genetic factors. All cat breeds face equal risk of developing blastomycosis if exposed to Blastomyces dermatitidis in endemic environments. Persian, Siamese, Maine Coon, domestic shorthair, and all other breeds show no difference in susceptibility. The disease affects cats based on their geographic location and outdoor exposure patterns rather than their breeding or genetic background.

Factors other than breed determine blastomycosis risk in individual cats. Geographic location in or travel through endemic areas is the fundamental risk factor. Outdoor access allowing exposure to contaminated soil environments is essential for infection acquisition. Lifestyle factors influencing time spent in high-risk environments affect exposure level. Age and sex distributions in case series suggest young male cats may be overrepresented, possibly reflecting greater roaming and environmental exploration behavior rather than inherent susceptibility differences. Immune status may influence whether exposure leads to clinical disease.

Screening recommendations for blastomycosis are based on clinical signs and geographic risk rather than breed. There is no genetic testing for blastomycosis susceptibility as it is an infectious condition without hereditary component. Cats in endemic areas presenting with respiratory disease, skin lesions, or eye abnormalities should be tested for blastomycosis regardless of breed. Awareness of endemic regions helps veterinarians and owners recognize when blastomycosis testing is appropriate. Any cat with compatible clinical signs and potential exposure history warrants evaluation for this fungal infection.

Several conditions commonly co-occur with or relate to blastomycosis in affected cats. Bacterial secondary infections may develop in damaged lung tissue or ulcerated skin lesions, complicating the clinical picture and requiring concurrent antibiotic therapy. Eye complications including glaucoma, retinal detachment, and blindness may result from ocular blastomycosis even with successful systemic treatment. Osteomyelitis from bone involvement can cause pathological fractures or persistent lameness. Immunocompromise from concurrent conditions such as FIV or FeLV infection may be present and affects prognosis.

Conditions with similar symptoms that must be differentiated from blastomycosis include other systemic mycoses and various non-fungal diseases. Histoplasmosis occurs in overlapping geographic regions and causes similar respiratory and systemic signs, requiring specific diagnostic testing for differentiation. Cryptococcosis is an important differential, particularly for cats with skin, nasal, or CNS involvement. Coccidioidomycosis in its endemic region can cause similar disease. Non-fungal conditions including lymphoma and other neoplasia may present similarly with pulmonary nodules, skin masses, and systemic illness. Bacterial or mycobacterial infections can mimic some presentations.

Potential complications of blastomycosis include consequences of both the infection and its treatment. Permanent vision loss from ocular involvement is common if eye disease was present. Chronic respiratory compromise may result from severe pulmonary infection even after treatment. Bone lesions may cause lasting orthopedic problems. Hepatotoxicity from prolonged itraconazole therapy requires monitoring and may necessitate treatment modification. Relapse following apparently successful treatment occurs in a subset of cases, requiring renewed therapy. Early diagnosis and treatment minimize the risk of permanent complications.